This is a competitive renewal for years 26 to 31 of an interdisciplinary drug abuse research training program. We seek to vigorously identify a highly talented group of postdoctoral researchers who we can train to integrate basic and translational research in the pharmacology, physiology and neurobiology of drug abuse. The program has a long and distinguished history and our past trainees have compiled a gratifying record of achievements. The program has been reconfigured to provide interdisciplinary training that maintains Sinai's historical strengths and takes advantage of new intellectual, educational, programmatic and physical resources of the school. Over the past six years Mount Sinai has recruited a highly renowned broad-based faculty in drug abuse research such as L. A. Devi (Director of this training program), Y. Hurd (Co-Director of this program), C. Alberini and most recently E. Nestler. Dr. Nestler will be heading the newly formed Brain Research Institute and the Department of Neuroscience. Mount Sinai has also embarked on a collaborative program with Brookhaven Laboratories to further develop live imaging modalities in substance abuse research. This program will train inter- and trans-disciplinary researchers who can go to develop independent and collaborative research programs that significantly advance the basic understanding and treatment of this important social and medical problem. The training program encourages participation of faculty mentors whose research grants do not specifically target drug abuse, but whose research is critically important for the interdisciplinary training we seek to impart, thus offering fellows flexibility in developing truly interdisciplinary research projects between laboratories. The training will have a didactic component to foster interdisciplinary reasoning skills and understand and maintain awareness of the ethical issues in research. The trainees will be provided guidance to develop independent research projects that can serve as the basis to launch successful independent careers in substance abuse research. Mount Sinai provides a fertile environment and significant resources for this important training program that will contribute robustly to the national pipeline of highly trained interdisciplinary investigators working on drug abuse research.

Public Health Relevance

We describe a training program that reflects this vision and that, we hope, will train researchers who provide significant advances in the basic understanding and treatment of drug addiction that is an important social and medical problem. This training program also offers fellows flexibility in obtaining an interdisciplinary training in drug abuse research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Institutional National Research Service Award (T32)
Project #
5T32DA007135-30
Application #
8469447
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Babecki, Beth
Project Start
1979-12-01
Project End
2014-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
30
Fiscal Year
2013
Total Cost
$222,850
Indirect Cost
$17,502
Name
Icahn School of Medicine at Mount Sinai
Department
Pharmacology
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Gupta, Achla; Gomes, Ivone; Bobeck, Erin N et al. (2016) Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity. Proc Natl Acad Sci U S A 113:6041-6
Gan, Gabriela; Preston-Campbell, Rebecca N; Moeller, Scott J et al. (2016) Reward vs. Retaliation-the Role of the Mesocorticolimbic Salience Network in Human Reactive Aggression. Front Behav Neurosci 10:179
Urban, Daniel J; Zhu, Hu; Marcinkiewcz, Catherine A et al. (2016) Elucidation of The Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons. Neuropsychopharmacology 41:1404-15
Gomes, Ivone; Bobeck, Erin N; Margolis, Elyssa B et al. (2016) Identification of GPR83 as the receptor for the neuroendocrine peptide PEN. Sci Signal 9:ra43
Koike, Hiroyuki; Demars, Michael P; Short, Jennifer A et al. (2016) Chemogenetic Inactivation of Dorsal Anterior Cingulate Cortex Neurons Disrupts Attentional Behavior in Mouse. Neuropsychopharmacology 41:1014-23
Koo, Ja Wook; Mazei-Robison, Michelle S; LaPlant, Quincey et al. (2015) Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental area. Nat Neurosci 18:415-22
Michaelides, Michael; Hurd, Yasmin L (2015) DREAMM: a biobehavioral imaging methodology for dynamic in vivo whole-brain mapping of cell type-specific functional networks. Neuropsychopharmacology 40:239-40
Walker, Deena M; Cates, Hannah M; Heller, Elizabeth A et al. (2015) Regulation of chromatin states by drugs of abuse. Curr Opin Neurobiol 30:112-21
Gupta, A; Fujita, W; Gomes, I et al. (2015) Endothelin-converting enzyme 2 differentially regulates opioid receptor activity. Br J Pharmacol 172:704-19
Heller, Elizabeth A; Kaska, Sophia; Fallon, Barbara et al. (2015) Morphine and cocaine increase serum- and glucocorticoid-inducible kinase 1 activity in the ventral tegmental area. J Neurochem 132:243-53

Showing the most recent 10 out of 92 publications